Lydia Marcella Tonantzin Torres, OD

Lydia Marcella Torres practices at Sharp Rees-Stealy Medical Group Inc in San Diego, California.

Lydia Marcella Torres' NPI, 1144295171, was assigned on February 22, 2006. Lydia Marcella Torres graduated from Berkeley Northeastern State University - College of Medicine in 2005. Lydia Marcella Torres holds California license OPT13114.

Lydia Marcella Torres' primary practice is Sharp Rees-Stealy Medical Group Inc, at 10243 Genetic Center Dr, San Diego, CA 92121 in San Diego County. The practice phone is (619) 446-1646.

Lydia Marcella Torres' primary practice is Sharp Rees-Stealy Medical Group Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Lydia Marcella Torres to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lydia Marcella Torres practices. Vendor and product names are available with a free account.

Ophthalmology is Lydia Marcella Torres' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Lydia Marcella Torres' licenses on file in 2 states: California and New York.

CMS data shows 284 Medicare services from Lydia Marcella Torres across 7 procedure codes in 2024, for 187 Medicare patients. Medicare paid $15,669 for them. Every service was in an office.

CMS counts 187 Medicare patients who saw Lydia Marcella Torres in 2024. The largest group is 65 to 74, with 88 patients. 63% of them have high cholesterol, and 60% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lydia Marcella Torres' median patient age at 67, with 64% women.

In 2024, Lydia Marcella Torres wrote 245 Medicare Part D claims for 100 patients. 28% of them were for generic drugs. CMS names the drug for 175 of them, across 5 drugs with 11 or more claims each, at $108,592 in total drug cost. In 2023, CMS named 169 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Lydia Marcella Torres for performance year 2024, reported as part of a group. Lydia Marcella Torres accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 76 general payments to Lydia Marcella Torres from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Shire North American Group Inc paid the most, $350.

Lydia Marcella Torres graduated from Berkeley Northeastern State University - College of Medicine in 2005.